13/04
Beckman Coulter Life Sciences and Amoy Diagnostics Sign Application Development Agreement for the Biomek Ngenius Next Generation Library Prep System
Xiamen, China April 13, 2022 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company, and Beckman Coulter Life Sciences, a global leader in life sciences lab automation and innovation, announce
08/04
AmoyDx Signs Strategic Cooperation Agreement with HUTCHMED in China
Xiamen, China - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company, and HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13), an innovative, commercial-stage, biopharmaceutical co
15/03
China's NMPA Granted Approval to AmoyDx® PD-L1 Expression Detection Kit (IHC)
Xiamen, China, March 15, 2022 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company today announced that China’s National Medical Products Administration (NMPA) recently granted Approval to A
14/03
Visit AmoyDx at AACR Annual Meeting 2022 in Louisiana, USA
AmoyDx is excited to be back in New Orleans, Louisiana, USA in April for American Association for Cancer Research (AACR) Annual Meeting 2022. Please plan to join us at booth 1265 from 10 - 13 April, 2022 and we look forward to seeing you in New Orleans.
24/02
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval of Companion Diagnostic Reagent for the AmoyDx® Pan Lung Cancer PCR Panel
TOKYO and XIAMEN, February 24, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that an application for partial revision of manufacturing and marketing approval for Am
24/02
AmoyDx Collaborates with Pierre Fabre to Develop Companion Diagnostics for China Market
Xiamen (China), Castres (France), February 23rd, 2022 – Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE:300685), and the French pharmaceutical group Pierre Fabre announced that the companies have entered into a collaboration to develop Companion Diagnostic (CDx)
Inquiry
* Required information
Manage your account info
Change your password